Literature DB >> 28778237

Depression and Hypersomnia: A Complex Association.

Régis Lopez1, Lucie Barateau2, Elisa Evangelista3, Yves Dauvilliers4.   

Abstract

Hypersomnolence is a clinically defined syndrome characterized by the association of prolonged nocturnal sleep, impaired arousal quality, and sleep inertia. Hypersomnolence is the major feature of central hypersomnias and is frequently reported in various mood disorders, such as major depressive disorder, bipolar disorder, or seasonal affective disorder. Assessment of hypersomnolence is challenging in depressed patients, with objective tests often in the normal range despite a high level of sleepiness complaint. On the other hand, many patients with central hypersomnias reported depressive symptoms. The self-assessment of mood symptoms in patients with central hypersomnias may overdiagnose depression with an overlap between both conditions.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Depression; Hypersomnia; Hypersomnolence; Mood; Sleepiness

Mesh:

Year:  2017        PMID: 28778237     DOI: 10.1016/j.jsmc.2017.03.016

Source DB:  PubMed          Journal:  Sleep Med Clin        ISSN: 1556-407X


  14 in total

Review 1.  Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.

Authors:  Steven T Szabo; Michael J Thorpy; Geert Mayer; John H Peever; Thomas S Kilduff
Journal:  Sleep Med Rev       Date:  2018-11-08       Impact factor: 11.609

2.  Prevalence, incidence, and health care utilization of patients with narcolepsy: a population-representative study.

Authors:  Ulf Kallweit; Georg Nilius; Daniel Trümper; Tobias Vogelmann; Tino Schubert
Journal:  J Clin Sleep Med       Date:  2022-06-01       Impact factor: 4.324

3.  Comorbidities in a community sample of narcolepsy.

Authors:  Alexander Cohen; Jay Mandrekar; Erik K St Louis; Michael H Silber; Suresh Kotagal
Journal:  Sleep Med       Date:  2017-11-21       Impact factor: 3.492

4.  Advance taper of antidepressants prior to multiple sleep latency testing increases the number of sleep-onset rapid eye movement periods and reduces mean sleep latency.

Authors:  Bhanu Prakash Kolla; Marjan Jahani Kondori; Michael H Silber; Hala Samman; Swati Dhankikar; Meghna P Mansukhani
Journal:  J Clin Sleep Med       Date:  2020-11-15       Impact factor: 4.062

Review 5.  The neurobiological basis of narcolepsy.

Authors:  Carrie E Mahoney; Andrew Cogswell; Igor J Koralnik; Thomas E Scammell
Journal:  Nat Rev Neurosci       Date:  2019-02       Impact factor: 34.870

6.  Self-reported symptoms and objective measures in idiopathic hypersomnia and hypersomnia associated with psychiatric disorders: a prospective cross-sectional study.

Authors:  Jitka Bušková; Tomáš Novák; Eva Miletínová; Radana Králová; Jana Košt Álová; Monika Kliková; Karolina Veldová
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

7.  Δ3,2-Hydroxybakuchiol Attenuates Depression in Multiple Rodent Models Possibly by Inhibition of Monoamine Transporters in Brain.

Authors:  Gang Zhao; Li-He Guo; Wei Huang; Jia-Liang Hu
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-20       Impact factor: 2.629

8.  Evaluation of the effect of insulin sensitivity-enhancing lifestyle- and dietary-related adjuncts on antidepressant treatment response: protocol for a systematic review and meta-analysis.

Authors:  Olaitan J Jeremiah; Gráinne Cousins; Finbarr P Leacy; Brian P Kirby; Benedict K Ryan
Journal:  Syst Rev       Date:  2019-02-25

Review 9.  Narcolepsy type 1: what have we learned from genetics?

Authors:  Hanna M Ollila
Journal:  Sleep       Date:  2020-11-12       Impact factor: 5.849

10.  The Habenula in the Link Between ADHD and Mood Disorder.

Authors:  Young-A Lee; Yukiori Goto
Journal:  Front Behav Neurosci       Date:  2021-06-24       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.